Industry Research Reports

Home > Reports > Medical Care > Global Oncolytic Virus Therapy Market Research Report 2026

Global Oncolytic Virus Therapy Market Research Report 2026

Industry: Medical Care

Published Date: 2026-01-04

Pages: 99 Pages

Report ld: 5532950

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Oncolytic Virus Therapy Market Size(US$)

CAGR 2026-2032

10.4%

Market Size,2032

USD 232

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 129 million

Market Forecast in 2032(Value)

US$ 232 million

CAGR

10.4%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Oncolytic Virus Therapy market was valued at US$ 118 million in 2025 and is anticipated to reach US$ 232 million by 2032, at a CAGR of 10.4% from 2026 to 2032.

Oncolytic Virus Therapy is an innovative cancer treatment approach that employs genetically modified viruses to selectively infect and destroy tumor cells while activating the host’s immune system to launch a systemic anti-tumor response. These viruses induce direct oncolysis and stimulate immunogenic cell death, positioning them as a pivotal class in immuno-oncology. Unlike chemotherapy or radiotherapy, this modality offers enhanced tumor selectivity, reduced toxicity, and strong synergistic potential when combined with immune checkpoint inhibitors. Products like Talimogene laherparepvec (T-VEC) have received FDA approval, showing promising efficacy in melanoma and drawing increasing R&D and commercial attention from global pharmaceutical companies.

With breakthroughs in immuno-oncology and the advancement of precision medicine, oncolytic virus therapy is entering a period of rapid growth. Global regulatory bodies are encouraging innovation through frameworks like the FDA's Breakthrough Therapy designation and the EU’s PRIME program, facilitating clinical acceleration and early commercialization. The increasing incidence of cancer, particularly advanced solid tumors, underscores the unmet demand for novel mechanisms of action. Furthermore, leading biopharmaceutical companies are actively investing in M&A and strategic partnerships in this space, significantly expanding their pipelines. Since 2023, several oncolytic virus candidates have advanced into Phase III trials, marking a clear shift toward industrial scalability.

Despite promising prospects, several key challenges persist in the development of oncolytic virus therapies. Efficient in vivo delivery and tumor-specific targeting remain technical hurdles, especially in patients with immunosuppressive microenvironments or rapid viral clearance. Clinical trials are resource-intensive, requiring long timelines, significant funding, and multidisciplinary collaboration spanning virology, immunology, and translational medicine. Safety concerns also linger, including risks of off-target infection and systemic inflammation. Additionally, the industry still lacks a broad base of commercially successful precedents, leading to cautious investment sentiment and uncertain return on investment timelines.

The downstream demand for innovative cancer therapies is rapidly rising, with oncolytic viruses increasingly recognized as critical components of next-generation immunotherapy combinations. In difficult-to-treat tumors such as glioblastoma, pancreatic cancer, and bladder cancer, preliminary data indicates enhanced efficacy when combined with checkpoint inhibitors like PD-1/PD-L1. Clinical practitioners and patient communities alike are showing growing interest. Moreover, the Asia-Pacific region is emerging as a significant growth engine, with supportive policies and increasing clinical trial activity in countries like China, Japan, and South Korea, paving the way for future regional commercialization strategies.

This report delivers a comprehensive overview of the global Oncolytic Virus Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oncolytic Virus Therapy. The Oncolytic Virus Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Oncolytic Virus Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Oncolytic Virus Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Amgen
RIGVIR Group
3s-guojian
Shuanghe Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

HSV-based Oncolytic Viruses
Adenoviruses-based Oncolytic Viruses
Vaccinia Virus-based Oncolytic Viruses
Vesicular Stomatitis Virus-based Oncolytic Viruses
Newcastle Disease Virus-based Oncolytic Viruses

Segment by Application

Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Oncolytic Virus Therapy companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 HSV-based Oncolytic Viruses

1.2.3 Adenoviruses-based Oncolytic Viruses

1.2.4 Vaccinia Virus-based Oncolytic Viruses

1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses

1.2.6 Newcastle Disease Virus-based Oncolytic Viruses

1.3 Market by Application

1.3.1 Global Oncolytic Virus Therapy Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Melanoma

1.3.3 Prostate Cancer

1.3.4 Breast Cancer

1.3.5 Ovarian Cancer

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oncolytic Virus Therapy Market Perspective (2021–2032)

2.2 Global Oncolytic Virus Therapy Growth Trends by Region

2.2.1 Global Oncolytic Virus Therapy Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Oncolytic Virus Therapy Historic Market Size by Region (2021–2026)

2.2.3 Oncolytic Virus Therapy Forecasted Market Size by Region (2027–2032)

2.3 Oncolytic Virus Therapy Market Dynamics

2.3.1 Oncolytic Virus Therapy Industry Trends

2.3.2 Oncolytic Virus Therapy Market Drivers

2.3.3 Oncolytic Virus Therapy Market Challenges

2.3.4 Oncolytic Virus Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oncolytic Virus Therapy Players by Revenue

3.1.1 Global Top Oncolytic Virus Therapy Players by Revenue (2021–2026)

3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2021–2026)

3.2 Global Top Oncolytic Virus Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Oncolytic Virus Therapy Revenue

3.4 Global Oncolytic Virus Therapy Market Concentration Ratio

3.4.1 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Therapy Revenue in 2025

3.5 Global Key Players of Oncolytic Virus Therapy Head Offices and Areas Served

3.6 Global Key Players of Oncolytic Virus Therapy, Products and Applications

3.7 Global Key Players of Oncolytic Virus Therapy, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Oncolytic Virus Therapy Breakdown Data by Type

4.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2021–2026)

4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2027–2032)

5 Oncolytic Virus Therapy Breakdown Data by Application

5.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2021–2026)

5.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Oncolytic Virus Therapy Market Size (2021–2032)

6.2 North America Oncolytic Virus Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Oncolytic Virus Therapy Market Size by Country (2021–2026)

6.4 North America Oncolytic Virus Therapy Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oncolytic Virus Therapy Market Size (2021–2032)

7.2 Europe Oncolytic Virus Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Oncolytic Virus Therapy Market Size by Country (2021–2026)

7.4 Europe Oncolytic Virus Therapy Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Oncolytic Virus Therapy Market Size (2021–2032)

8.2 Asia-Pacific Oncolytic Virus Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2021–2026)

8.4 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Oncolytic Virus Therapy Market Size (2021–2032)

9.2 Latin America Oncolytic Virus Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Oncolytic Virus Therapy Market Size by Country (2021–2026)

9.4 Latin America Oncolytic Virus Therapy Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oncolytic Virus Therapy Market Size (2021–2032)

10.2 Middle East & Africa Oncolytic Virus Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2021–2026)

10.4 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Oncolytic Virus Therapy Introduction

11.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2021–2026)

11.1.5 Amgen Recent Development

11.2 RIGVIR Group

11.2.1 RIGVIR Group Company Details

11.2.2 RIGVIR Group Business Overview

11.2.3 RIGVIR Group Oncolytic Virus Therapy Introduction

11.2.4 RIGVIR Group Revenue in Oncolytic Virus Therapy Business (2021–2026)

11.2.5 RIGVIR Group Recent Development

11.3 3s-guojian

11.3.1 3s-guojian Company Details

11.3.2 3s-guojian Business Overview

11.3.3 3s-guojian Oncolytic Virus Therapy Introduction

11.3.4 3s-guojian Revenue in Oncolytic Virus Therapy Business (2021–2026)

11.3.5 3s-guojian Recent Development

11.4 Shuanghe Pharmaceutical

11.4.1 Shuanghe Pharmaceutical Company Details

11.4.2 Shuanghe Pharmaceutical Business Overview

11.4.3 Shuanghe Pharmaceutical Oncolytic Virus Therapy Introduction

11.4.4 Shuanghe Pharmaceutical Revenue in Oncolytic Virus Therapy Business (2021–2026)

11.4.5 Shuanghe Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of HSV-based Oncolytic Viruses

Table 3. Key Players of Adenoviruses-based Oncolytic Viruses

Table 4. Key Players of Vaccinia Virus-based Oncolytic Viruses

Table 5. Key Players of Vesicular Stomatitis Virus-based Oncolytic Viruses

Table 6. Key Players of Newcastle Disease Virus-based Oncolytic Viruses

Table 7. Global Oncolytic Virus Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 8. Global Oncolytic Virus Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 9. Global Oncolytic Virus Therapy Market Size by Region (US$ Million), 2021–2026

Table 10. Global Oncolytic Virus Therapy Market Share by Region (2021–2026)

Table 11. Global Oncolytic Virus Therapy Forecasted Market Size by Region (US$ Million), 2027–2032

Table 12. Global Oncolytic Virus Therapy Market Share by Region (2027–2032)

Table 13. Oncolytic Virus Therapy Market Trends

Table 14. Oncolytic Virus Therapy Market Drivers

Table 15. Oncolytic Virus Therapy Market Challenges

Table 16. Oncolytic Virus Therapy Market Restraints

Table 17. Global Oncolytic Virus Therapy Revenue by Players (US$ Million), 2021–2026

Table 18. Global Oncolytic Virus Therapy Market Share by Players (2021–2026)

Table 19. Global Top Oncolytic Virus Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Oncolytic Virus Therapy Revenue, 2025

Table 20. Ranking of Global Top Oncolytic Virus Therapy Companies by Revenue (US$ Million) in 2025

Table 21. Global 5 Largest Players Market Share by Oncolytic Virus Therapy Revenue (CR5 and HHI), 2021–2026

Table 22. Global Key Players of Oncolytic Virus Therapy, Headquarters and Area Served

Table 23. Global Key Players of Oncolytic Virus Therapy, Products and Applications

Table 24. Global Key Players of Oncolytic Virus Therapy, Date of General Availability (GA)

Table 25. Mergers and Acquisitions, Expansion Plans

Table 26. Global Oncolytic Virus Therapy Market Size by Type (US$ Million), 2021–2026

Table 27. Global Oncolytic Virus Therapy Revenue Market Share by Type (2021–2026)

Table 28. Global Oncolytic Virus Therapy Forecasted Market Size by Type (US$ Million), 2027–2032

Table 29. Global Oncolytic Virus Therapy Revenue Market Share by Type (2027–2032)

Table 30. Global Oncolytic Virus Therapy Market Size by Application (US$ Million), 2021–2026

Table 31. Global Oncolytic Virus Therapy Revenue Market Share by Application (2021–2026)

Table 32. Global Oncolytic Virus Therapy Forecasted Market Size by Application (US$ Million), 2027–2032

Table 33. Global Oncolytic Virus Therapy Revenue Market Share by Application (2027–2032)

Table 34. North America Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. North America Oncolytic Virus Therapy Market Size by Country (US$ Million), 2021–2026

Table 36. North America Oncolytic Virus Therapy Market Size by Country (US$ Million), 2027–2032

Table 37. Europe Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 38. Europe Oncolytic Virus Therapy Market Size by Country (US$ Million), 2021–2026

Table 39. Europe Oncolytic Virus Therapy Market Size by Country (US$ Million), 2027–2032

Table 40. Asia-Pacific Oncolytic Virus Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 41. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (US$ Million), 2021–2026

Table 42. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (US$ Million), 2027–2032

Table 43. Latin America Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Latin America Oncolytic Virus Therapy Market Size by Country (US$ Million), 2021–2026

Table 45. Latin America Oncolytic Virus Therapy Market Size by Country (US$ Million), 2027–2032

Table 46. Middle East & Africa Oncolytic Virus Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 47. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (US$ Million), 2021–2026

Table 48. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (US$ Million), 2027–2032

Table 49. Amgen Company Details

Table 50. Amgen Business Overview

Table 51. Amgen Oncolytic Virus Therapy Product

Table 52. Amgen Revenue in Oncolytic Virus Therapy Business (US$ Million), 2021–2026

Table 53. Amgen Recent Development

Table 54. RIGVIR Group Company Details

Table 55. RIGVIR Group Business Overview

Table 56. RIGVIR Group Oncolytic Virus Therapy Product

Table 57. RIGVIR Group Revenue in Oncolytic Virus Therapy Business (US$ Million), 2021–2026

Table 58. RIGVIR Group Recent Development

Table 59. 3s-guojian Company Details

Table 60. 3s-guojian Business Overview

Table 61. 3s-guojian Oncolytic Virus Therapy Product

Table 62. 3s-guojian Revenue in Oncolytic Virus Therapy Business (US$ Million), 2021–2026

Table 63. 3s-guojian Recent Development

Table 64. Shuanghe Pharmaceutical Company Details

Table 65. Shuanghe Pharmaceutical Business Overview

Table 66. Shuanghe Pharmaceutical Oncolytic Virus Therapy Product

Table 67. Shuanghe Pharmaceutical Revenue in Oncolytic Virus Therapy Business (US$ Million), 2021–2026

Table 68. Shuanghe Pharmaceutical Recent Development

Table 69. Research Programs/Design for This Report

Table 70. Key Data Information from Secondary Sources

Table 71. Key Data Information from Primary Sources

Table 72. Authors List of This Report

List of Figures

Figure 1. Oncolytic Virus Therapy Picture

Figure 2. Global Oncolytic Virus Therapy Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Oncolytic Virus Therapy Market Share by Type: 2025 vs 2032

Figure 4. HSV-based Oncolytic Viruses Features

Figure 5. Adenoviruses-based Oncolytic Viruses Features

Figure 6. Vaccinia Virus-based Oncolytic Viruses Features

Figure 7. Vesicular Stomatitis Virus-based Oncolytic Viruses Features

Figure 8. Newcastle Disease Virus-based Oncolytic Viruses Features

Figure 9. Global Oncolytic Virus Therapy Market Size by Application (US$ Million), 2021–2032

Figure 10. Global Oncolytic Virus Therapy Market Share by Application: 2025 vs 2032

Figure 11. Melanoma Case Studies

Figure 12. Prostate Cancer Case Studies

Figure 13. Breast Cancer Case Studies

Figure 14. Ovarian Cancer Case Studies

Figure 15. Others Case Studies

Figure 16. Oncolytic Virus Therapy Report Years Considered

Figure 17. Global Oncolytic Virus Therapy Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 18. Global Oncolytic Virus Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Oncolytic Virus Therapy Market Share by Region: 2025 vs 2032

Figure 20. Global Oncolytic Virus Therapy Market Share by Players in 2025

Figure 21. Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. The Top 10 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2025

Figure 23. North America Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. North America Oncolytic Virus Therapy Market Share by Country (2021–2032)

Figure 25. United States Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Canada Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Europe Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Europe Oncolytic Virus Therapy Market Share by Country (2021–2032)

Figure 29. Germany Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. France Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. U.K. Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Italy Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Russia Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Ireland Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Asia-Pacific Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Asia-Pacific Oncolytic Virus Therapy Market Share by Region (2021–2032)

Figure 37. China Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Japan Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. South Korea Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Southeast Asia Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. India Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Australia & New Zealand Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Latin America Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Latin America Oncolytic Virus Therapy Market Share by Country (2021–2032)

Figure 45. Mexico Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Brazil Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Middle East & Africa Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Middle East & Africa Oncolytic Virus Therapy Market Share by Country (2021–2032)

Figure 49. Israel Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Saudi Arabia Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. UAE Oncolytic Virus Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Amgen Revenue Growth Rate in Oncolytic Virus Therapy Business (2021–2026)

Figure 53. RIGVIR Group Revenue Growth Rate in Oncolytic Virus Therapy Business (2021–2026)

Figure 54. 3s-guojian Revenue Growth Rate in Oncolytic Virus Therapy Business (2021–2026)

Figure 55. Shuanghe Pharmaceutical Revenue Growth Rate in Oncolytic Virus Therapy Business (2021–2026)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Oncolytic Virus Therapy market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global Oncolytic Virus Therapy market is 10.4% 2026 to 2032.

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Oncolytic Virus Therapy market? shouQi

What was the global market size of Oncolytic Virus Therapy in 2026? shouQi

What was the global market size of Oncolytic Virus Therapy in 2032? shouQi

Related Reports

Global Oncolytic Virus Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Oncolytic Virus Therapy market size was US$ 118 million in 2025 and is forecast to reach a readjusted size of US$ 232 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 67
USD 4250.00
(Single User License)
Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 118 million in 2025 and is projected to reach US$ 232 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 73
USD 3950.00
(Single User License)
Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 106 million in 2024 and is forecast to a readjusted size of US$ 213 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published Date: 2025-10-21
Pages: 77
USD 3950.00
(Single User License)
Global Oncolytic Virus Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Oncolytic Virus Therapy market is projected to grow from US$ 106 million in 2024 to US$ 213 million by 2031, at a CAGR of 10.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 103
USD 4900.00
(Single User License)
Global Oncolytic Virus Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oncolytic Virus Therapy market size was US$ 106 million in 2024 and is forecast to a readjusted size of US$ 213 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published Date: 2025-08-13
Pages: 67
USD 4250.00
(Single User License)
Global Oncolytic Virus Therapy Market Research Report 2025
The global market for Oncolytic Virus Therapy was valued at US$ 106 million in the year 2024 and is projected to reach a revised size of US$ 213 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Published Date: 2025-08-13
Pages: 67
USD 2900.00
(Single User License)
Global Oncolytic Virus Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Oncolytic Virus Therapy was estimated to be worth US$ 9.3 million and is forecast to reach approximately US$ 43.3 million by 2031 with a CAGR of 24.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 135
USD 5900.00
(Single User License)
Oncolytic Virus Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 9.3 million in 2024 and is forecast to a readjusted size of US$ 43.3 million by 2031 with a CAGR of 24.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 117
USD 3950.00
(Single User License)
Global Oncolytic Virus Therapy Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Published Date: 2024-04-17
Pages: 151
USD 5600.00
(Single User License)
Global Oncolytic Virus Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Published Date: 2024-04-16
Pages: 146
USD 5900.00
(Single User License)

Global Oncolytic Virus Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Oncolytic Virus Therapy market size was US$ 118 million in 2025 and is forecast to reach a readjusted size of US$ 232 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 67
USD 4250.00 (Single User License)
Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 118 million in 2025 and is projected to reach US$ 232 million, growing at a CAGR of 10.4% from 2026 to 2032.
Published: 2026-01-04
Pages: 73
USD 3950.00 (Single User License)
Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 106 million in 2024 and is forecast to a readjusted size of US$ 213 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published: 2025-10-21
Pages: 77
USD 3950.00 (Single User License)
Global Oncolytic Virus Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Oncolytic Virus Therapy market is projected to grow from US$ 106 million in 2024 to US$ 213 million by 2031, at a CAGR of 10.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 103
USD 4900.00 (Single User License)
Global Oncolytic Virus Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Oncolytic Virus Therapy market size was US$ 106 million in 2024 and is forecast to a readjusted size of US$ 213 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published: 2025-08-13
Pages: 67
USD 4250.00 (Single User License)
Global Oncolytic Virus Therapy Market Research Report 2025
The global market for Oncolytic Virus Therapy was valued at US$ 106 million in the year 2024 and is projected to reach a revised size of US$ 213 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Published: 2025-08-13
Pages: 67
USD 2900.00 (Single User License)
Global Oncolytic Virus Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Oncolytic Virus Therapy was estimated to be worth US$ 9.3 million and is forecast to reach approximately US$ 43.3 million by 2031 with a CAGR of 24.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 135
USD 5900.00 (Single User License)
Oncolytic Virus Therapy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Oncolytic Virus Therapy was estimated to be worth US$ 9.3 million in 2024 and is forecast to a readjusted size of US$ 43.3 million by 2031 with a CAGR of 24.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 117
USD 3950.00 (Single User License)
Global Oncolytic Virus Therapy Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Published: 2024-04-17
Pages: 151
USD 5600.00 (Single User License)
Global Oncolytic Virus Therapy Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Published: 2024-04-16
Pages: 146
USD 5900.00 (Single User License)